Bayer Aktiengesellschaft (ETR:BAYN – Get Free Report) rose 0.2% on Thursday . The stock traded as high as €21.77 ($22.68) and last traded at €21.54 ($22.44). Approximately 3,248,785 shares were traded during mid-day trading, The stock had previously closed at €21.50 ($22.39).
Bayer Aktiengesellschaft Trading Up 0.2 %
The firm has a market cap of $21.16 billion, a price-to-earnings ratio of -16.70, a price-to-earnings-growth ratio of 36.39 and a beta of 0.97. The company has a quick ratio of 0.72, a current ratio of 1.27 and a debt-to-equity ratio of 129.94. The business has a 50 day moving average price of €19.80 and a 200-day moving average price of €24.31.
About Bayer Aktiengesellschaft
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Further Reading
- Five stocks we like better than Bayer Aktiengesellschaft
- 3 Stocks to Consider Buying in October
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Canadian Penny Stocks: Can They Make You Rich?
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
